- ►endojournals.org A Colao, D Ferone, P Marzullo, G Lombardi - Endocrine Reviews, 2004 - Endocrine Soc This review focuses on the systemic complications of acromegaly. Mortality in
this disease is increased mostly because of cardiovascular and respiratory
diseases, although currently neoplastic complications have been questioned ... Cited by 266 - Related articles - BL Direct - All 4 versions
- ►nih.gov A Ben-Shlomo, S Melmed - Endocrinology and metabolism clinics of North America, 2001 - Elsevier Acromegaly, a somatic growth and proportion disorder first described by Marie in
1886, 68 occurs with an annual incidence of approximately 1000 patients.
Elevated levels of growth hormone and insulin-like growth factor 1 (IGF-1) ... Cited by 41 - Related articles - BL Direct - All 6 versions
- ►nih.gov J Ayuk, MC Sheppard - British Medical Journal, 2006 - pmj.bmj.com Growth hormone (GH) is synthesised and secreted by the somatotroph cells of the
anterior lobe of the pituitary gland. Its actions involve multiple organs and
systems, affecting postnatal longitudinal growth as well as protein, lipid, ... Cited by 27 - Related articles - BL Direct - All 8 versions
- ►endojournals.org A Tagliafico, E Resmini, R Nizzo, F Bianchi, F … - Journal of Clinical Endocrinology & Metabolism, 2008 - Endocrine Soc Objective: Our objective was to examine median (MN) and ulnar nerves (UN) of
acromegalic patients with ultrasound (US) and to determine whether nerve
abnormalities correlate with clinical parameters and nerve conduction ... Cited by 7 - Related articles - BL Direct - All 3 versions
P Chanson, S Salenave - Orphanet Journal of Rare Diseases, 2008 - biomedcentral.com Acromegaly is an acquired disorder related to excessive production of growth
hormone (GH) and characterized by progressive somatic disfigurement (mainly
involving the face and extremities) and systemic manifestations. The ... Cited by 8 - Related articles - Cached - All 12 versions
A Colao, AL Barkan, R Scarpa - Rheumatic Disease Clinics of NOrth America, 2005 - Elsevier The lack of the in vitro response of cartilage to growth hormone (GH) prompted
Salmon and Daughaday [1] to suggest the existence of a secondary
mediator—initially named somatomedin and today known as insulin-like ... Cited by 6 - Related articles - All 11 versions
S Stavrou, DL Kleinberg - Current Rheumatology Reports, 2001 - Springer Introduction Pituitary tumors are either hormone producing or nonsecre- tory
adenomas. Both may cause pituitary hormone insufficiency. Treatment of the
pituitary tumors with surgery or radiation may cause hypopituitarism. ... Cited by 3 - Related articles - BL Direct - All 3 versions
R Cozzi, R Attanasio - Expert Review of Endocrinology and Metabolism, 2007 - ingentaconnect.com Octreotide has dramatically changed the results of medical treatment of
acromegaly. It is the reference drug for the pharmacological treatment of
acromegaly, owing to its impressive efficacy in suppressing growth hormome ... Cited by 3 - Related articles - All 3 versions
- ►eje.org A Tagliafico, E Resmini, R Nizzo, LE Derchi, F … - European Journal of Endocrinology, 2008 - eje.org Patients: We examined prospectively 37 acromegalic patients with no history of
polyneuropathy, acute trauma at the elbow, no diabetes or hypothyroidism with
clinical examination, nerve conduction studies (NCS), and high-resolution ... Cited by 3 - Related articles - All 7 versions
E Resmini, A Tagliafico, R Nizzo, F Bianchi, F … - Clinical endocrinology, 2008 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Related articles - All 3 versions
